PMID: 11339503May 8, 2001Paper

Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat

Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
Audrey UknisRobert W Colman

Abstract

We studied the ability of bradykinin (BK) receptor antagonists type 1 and 2 (B1-RA, B2-RA) to prevent acute inflammation. A peptidoglycan-polysaccharide (PG-APS)-induced model of arthritis in the Lewis rat was analyzed. Four groups of animals were studied for 5 days. Treatment was administered subcutaneously (s.c.) 1 mg/kg every 12 h. Group I received PG-APS and was treated with the B2-RA, CP-0597 (DArg-Arg-Pro-Hyp-Gly-Thi-Ser-DTic-NChg-Arg). Group II received PG-APS and was treated with a combined B1 and B2-RA, B9430 (DArg-Arg-Pro-Hyp-Gly-Igl-Ser-Dlgl-Oic-Arg). Group III received PG-APS and albumin control. Group IV received albumin control. Joint diameter, liver weight, hematocrit, white blood count and plasma concentrations of prekallikrein, high molecular weight kininogen, HK and IL-beta were measured. Groups were compared by ANOVA. Acute arthritis and hepatomegaly were attenuated in the B2-RA-treated animals (p<0.05). Weight loss was more pronounced in the B1/B2-RA-treated animals. Anemia induced by PG-APS was prevented by B2-RA and B1/B2-RA treatment (p<0.001). A marked decrease in plasma HK to 64% of normal was found in the disease-untreated animals, which was completely normalized by B2-RA treatment and partially attenu...Continue Reading

Citations

Dec 20, 2002·International Immunopharmacology·Irma Isordia-SalasRobert W Colman
Apr 17, 2004·American Journal of Respiratory and Critical Care Medicine·Borja G CosíoIan M Adcock
Jul 1, 2005·Arthritis Research & Therapy·James C KeithRobert W Colman
Feb 5, 2009·Kidney International·Masao Kakoki, Oliver Smithies
Jul 21, 2015·The Journal of Clinical Investigation·Jenny BjörkqvistThomas Renné
Jan 10, 2008·International Immunopharmacology·U Schulze-TopphoffO Aktas
Aug 28, 2004·The American Journal of Pathology·Ricardo G EspinolaRobert W Colman
Oct 2, 2004·Nature Reviews. Drug Discovery·François Marceau, Domenico Regoli
Apr 5, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Antoni StadnickiRobert W Colman
Apr 18, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Razao IssaKian Fan Chung
Aug 16, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Aizhen YangYi Wu
Mar 6, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I M SainzR W Colman
Feb 10, 2016·Biological Chemistry·Yahaira M NaaldijkHenning Ulrich
Jun 18, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Irma Isordia-SalasRobert W Colman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.